HilaMilo Rasouly United StatesColumbia University

Hila Milo Rasouly is an Assistant Professor of Medical Sciences in the Department of Medicine and the Associate Director of Education of the Center for Precision Medicine and Genomics at Columbia University. She has a master in Genetic Counseling from the Hebrew University in Jerusalem, Israel and a Ph.D. in Genetics and Genomics from Boston University, MA. Her research interests are focused on the implementation of genomics in internal medicine.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	APOL1 Targeted Therapies: Who to Test and Which Disease to Treat? SK100 Fatiu AbiolaArogundade Chairperson NigeriaObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria FernandaSales Luiz Vianna Chairperson fslvianna@gmail.comBrazilUniversidade Federal do Rio Grande do Sul OpeyemiOlabisi Chairperson opeyemi.olabisi@duke.eduUnited StatesDuke University School of Medicine Ethical Aspects of Race-based Genetic Testing AnaIltis Speaker iltisas@wfu.eduUnited StatesWake Forest University Contribution of ApoL1 Risk Genotype to HIVAN SaraladeviNaicker Speaker South AfricaUniversity of the Witwatersrand Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa DwomoaAdu Speaker dwoms@blueyonder.co.ukGhanaUniversity of Ghana Medical School Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials OgoEgbuna Speaker ogo_egbuna@vrtx.comUnited StatesVertex Pharmaceuticals Inc Q and A Hall C2
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja Hall A
12:15 p.m. 1:15 p.m.	Hot Debate: Should a Low Protein Diet (+/- Ketoanalogue Supplementation) Be Part of Advanced CKD Management? LF02 CarlaAvesani Chairperson carla.avesani@ki.seSwedenKarolinska Institute SahirKalim Chairperson skalim@mgh.harvard.eduUnited StatesHarvard Medical School/ Massachusetts General Hospital Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - PROS ConnieRhee Speaker crhee@mednet.ucla.eduUnited StatesUCLA Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - CONS SwapnilHiremath Speaker CanadaUniversity of Ottawa Hall A
3 p.m. 4 p.m.	Kidney Health for All - Advancing Equitable Access to Care and Optimal Medication Practice: WKD Session BKH1003 DinaAbdellatif Chairperson EgyptCairo University Hospital VassiliosLiakopoulos Chairperson liakopul@otenet.grGreece2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thesalloniki, Greece Building Bridges to Reduce Fragmentation of Kidney Care RicardoCorrea Rotter Speaker correarotter@gmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Transforming Kidney Care Through Equitable Breakthrough Therapies KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology Closing the Gaps: Implementing Best Practices for CKD Care Worldwide ValerieLuyckx Speaker valerie.luyckx@uzh.chSwitzerlandUniversity of Zurich A Patient's Perspective on Gaps in Care MariaSeijas Speaker Mseijas@ifc.orgArgentinaCFA Q and A Hall C1
4:30 p.m. 5:30 p.m.	Policy and Advocacy Approaches BKH02 Lori-AnnFisher Chairperson JamaicaUniversity of the West Indies, Mona MarcelloTonelli Chairperson CanadaUniversity of Calgary Universal Health Coverage for Kidney Diseases: Feasibility, Barriers, and Opportunities for Improving Global Kidney Health VivekanandJha Speaker IndiaGeorge Institute for Global Health India The Role of Kidney Health Advocacy Organizations in Reducing the Global Burden of Kidney Diseases ValerieLuyckx Speaker valerie.luyckx@uzh.chSwitzerlandUniversity of Zurich A Case for National Prevention Programs to Manage CKD IkechiOkpechi Speaker CanadaUniversity of Alberta Q and A Hall A

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Genetics and Genomics of Rare Kidney Disease: ISN-Indian SN Joint Session SK03 PaulaCoccia Chairperson paula.coccia@hospitalitaliano.org.arArgentinaHospital Italianod de Buenos Aires Shyam BihariBansal Chairperson IndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Genomics of Rare Genetic Diseases: Experiences From India VinodScaria Speaker vinods@igib.inIndiaVishwanath Cancer Care Foundation & Indian Institute of Technology Kanpur On the Way to Translate GWAS into Kidney Disease Mechanisms KrzysztofKiryluk Speaker United StatesColumbia University X-linked Kidney Disorders in Women MichelleRheault Speaker rheau002@umn.eduUnited StatesUniversity of Minnesota Prenatal/Preimplantation Genetic Diagnosis and Genetic Counseling for Genetic Kidney Disorders NineKnoers Speaker v.v.a.m.knoers@umcg.nlNetherlandsDepartment of Genetics, University Medical Centre Groningen, Groningen, The Netherlands Q and A Hall E
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) PL3 Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/ Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? SK04 MartaAdragna Chairperson marta.adragna@gmail.comArgentina MoumitaBarua Chairperson moumita.barua@uhn.caCanada Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? - All Patients Albertien M.Van Eerde Speaker NetherlandsDepartment of Genetics, UMC Utrecht, The Netherlands Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? High-risk Populations Only HilaMilo Rasouly Speaker Hila.MiloRasouly@columbia.eduUnited StatesColumbia University Hall A
12:45 p.m. 1:30 p.m.	Keys to success to be on top of what is published in nephrology (ISN-ACT) SPOT-15 AndreaViecelli Spotlight Speaker AustraliaUniversity of Queensland Augusto CesarSoares dos Santos Junior Spotlight Speaker BrazilHospital das Clinicas, UFMG; Fac Ciências Medicas BrendanSmyth Spotlight Speaker brendan.smyth@sydney.edu.auAustralia DavidWheeler Spotlight Speaker United KingdomUniversity College London MegJardine Spotlight Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Spotlight Stage 1 (exhibition hall)
3 p.m. 4 p.m.	Disparities in the Care of People Living with Kidney Failure in Latin America LF1004 AdeeraLevin Chairperson CanadaUniversity of British Columbia and Providence Health Care AminuBello Chairperson CanadaUniversity of Alberta Global Assessment of Kidney Care Capacity and Policy and Perspectives on Enhancing Global Kidney Care-Findings From the ISN-GKHA AminuBello Speaker CanadaUniversity of Alberta State of CKD Care for Kidney Disease in Latin American Region Magdalena Madero Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiol Variability in The Burden, Management and Outcomes of Kidney Failure Between Children and Adults in Latin America MarinaWainstein Speaker ArgentinaAcademia Nacional de Medicina de Buenos Aires Q and A Hall C1
4:30 p.m. 5:30 p.m.	Designing Smart Clinical Trials SK05 DebbieGipson Chairperson debbie.gipson@nih.govUnited StatesNational Institutes of Health/NIDDK JonathanBarratt Chairperson United KingdomUniversity of Leicester, Leicester, UK Patients Subphenotyping: The Example of Diabetic Kidney Disease John CijiangHe Speaker cijiang.he@mssm.eduUnited StatesIcahn School of Medicine at Mount Sinai Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan Targeted Approaches in Clinical Trial Design HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

12:30 p.m. 1:30 p.m.	Rare and Orphan Diseases SK07 AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States RobertaFenoglio Chairperson roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina Alport Spectrum Disorders (Genetics) MoumitaBarua Speaker moumita.barua@uhn.caCanada Genetics of Nephrotic Syndrome SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduUnited StatesColumbia University Lupus Nephritis Transcriptomics Across Time and Space AnaMalvar Speaker avmperrin@yahoo.com.arArgentinaHospotal Fernandez, Organizacion Medica de Investigacion Q and A Hall E

Time

Session

12:30 p.m.

1:30 p.m.

Rare and Orphan Diseases

SK07

AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States

RobertaFenoglio Chairperson roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco

VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina

Alport Spectrum Disorders (Genetics)

MoumitaBarua Speaker moumita.barua@uhn.caCanada
Genetics of Nephrotic Syndrome

SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduUnited StatesColumbia University
Lupus Nephritis Transcriptomics Across Time and Space

AnaMalvar Speaker avmperrin@yahoo.com.arArgentinaHospotal Fernandez, Organizacion Medica de Investigacion
Q and A

Hall E

Pre-Congress - Saturday April 13, 2024

Time	Session

4:30 p.m. 6 p.m.	WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina) OCPL1 ISN President's Address MasaomiNangaku Speaker Japan Tribute to Stewart Cameron Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology JorgeRico Speaker jorgericof@yahoo.comColombia MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina Welcome by Minister of Health for Buenos Aries Dr Fern Welcome by SPWG Chair Alessia Fornoni AlessiaFornoni Speaker United StatesUniversity of Miami The Origin of the Universe DanielDe Florian Speaker deflo@unsam.edu.arArgentinaUniversidad Nacional de San Martin Acceptance Speech: Hamburger Award AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care Hall A
6:45 p.m. 7:15 p.m.	Building Renal Registry Capacity: Introducing ISN SPOT-02 EtienneNtabanganyimana Spotlight Speaker Rwanda MariaPippias Spotlight Speaker United KingdomUniversity of Bristol FergusCaskey Spotlight Chairperson United KingdomUniversity of Bristol, UK MariaGonzalez Spotlight Chairperson registro@slanh.netUruguaySLANH Spotlight Stage 1 (exhibition hall)